These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6706408)

  • 21. A mouse model of pneumonitis induced by Chlamydia trachomatis: morphologic, microbiologic, and immunologic studies.
    Chen W; Kuo C
    Am J Pathol; 1980 Aug; 100(2):365-82. PubMed ID: 7406016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infection.
    Ramsey KH; Shaba N; Cohoon KP; Ault KA
    Infect Dis Obstet Gynecol; 2003; 11(2):81-7. PubMed ID: 14627213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Chlamydia trachomatis MoPn enter a microbiologically-inapparent state during experimental infection of the mouse genital tract?
    Beale AS
    Microb Pathog; 1997 Feb; 22(2):99-112. PubMed ID: 9049999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reinfection of the mouse genital tract with Chlamydia trachomatis: the relationship of antibody to immunity.
    Tuffrey M; Falder P; Taylor-Robinson D
    Br J Exp Pathol; 1984 Feb; 65(1):51-8. PubMed ID: 6696831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia trachomatis-induced salpingitis in mice.
    Swenson CE; Donegan E; Schachter J
    J Infect Dis; 1983 Dec; 148(6):1101-7. PubMed ID: 6655289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
    Pal S; Peterson EM; de la Maza LM
    Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males.
    Pal S; Peterson EM; de la Maza LM
    Infect Immun; 2004 Jul; 72(7):4210-6. PubMed ID: 15213165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary murine Chlamydia trachomatis pneumonia in B-cell-deficient mice.
    Williams DM; Grubbs B; Schachter J
    Infect Immun; 1987 Oct; 55(10):2387-90. PubMed ID: 3498690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection.
    Vanrompay D; Hoang TQ; De Vos L; Verminnen K; Harkinezhad T; Chiers K; Morré SA; Cox E
    Infect Immun; 2005 Dec; 73(12):8317-21. PubMed ID: 16299329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.
    Cui ZD; Tristram D; LaScolea LJ; Kwiatkowski T; Kopti S; Ogra PL
    Infect Immun; 1991 Apr; 59(4):1465-9. PubMed ID: 2004824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice.
    Essig A; Rudolphi A; Heinemann M; Rosenthal H; Kaufmann R; Reimann J; Marre R
    Infect Immun; 1996 Jun; 64(6):2300-7. PubMed ID: 8675341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Roles of Toll-like receptor 2 (TLR2) and TLR4 in immune responses to Chlamydia trachomatis genital tract infection in mice].
    Wang Z; Chang X; Hao M; Song G; Zhu X; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Oct; 31(10):1336-41. PubMed ID: 26429534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of serology in diagnosing chlamydial infections of the female genital tract.
    Schachter J; Cles L; Ray R; Hines PA
    J Clin Microbiol; 1979 Nov; 10(5):647-9. PubMed ID: 397220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis.
    Johansson M; Ward M; Lycke N
    Immunology; 1997 Dec; 92(4):422-8. PubMed ID: 9497482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia trachomatis immunotypes in Finland.
    Saikku P; Wang SP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):131-4. PubMed ID: 3296651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3H male mice with severe combined immunodeficiency cannot clear a urethral infection with a human serovar of Chlamydia trachomatis.
    Pal S; Sarcon AK; de la Maza LM
    Infect Immun; 2009 Dec; 77(12):5602-7. PubMed ID: 19805533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
    Morrison RP; Feilzer K; Tumas DB
    Infect Immun; 1995 Dec; 63(12):4661-8. PubMed ID: 7591120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice.
    Sangaré L; Morisset R; Gaboury L; Ravaoarinoro M
    J Antimicrob Chemother; 2001 Mar; 47(3):323-31. PubMed ID: 11222565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.